Could a clay supplement help fight obesity?

NCT ID NCT07103382

Recruiting now Disease control Sponsor: Second Xiangya Hospital of Central South University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study is testing whether a dietary supplement called attapulgite can help people with obesity or overweight with type 2 diabetes lose weight safely. Forty participants will take either attapulgite or a placebo daily for 12 weeks. Researchers will measure changes in BMI, weight, and body fat.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: attapulgite (a dietary supplement)
What this could lead to: If it works, this could point toward a new, simple supplement to help with weight loss in people with obesity or type 2 diabetes.
What could go wrong: This is a very early, small exploratory trial with only 40 people. It may not show significant weight loss, and results may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OBESITY

Contacts and locations

Locations

Institute of Metabolism and Endocrinology, Second Xiangya Hospital, Central South University
RECRUITING

Changsha, Hunan, 410011, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.